Comparing smoking cessation methods for lung cancer screening patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of two smoking cessation interventions among individuals undergoing lung cancer screening. It focuses on improving treatment delivery to underserved populations and assesses both self-reported and bioverified abstinence from cigarettes at three and six months. The study also includes an economic analysis to evaluate the costs of the interventions from a health system perspective. By integrating cessation treatment with lung cancer screening, the study seeks to enhance patient outcomes and reduce lung cancer deaths.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* eligible for a screening or diagnostic scan,
* USPSTF eligibility criteria (50-80 years old and \>20-pack years);
* currently smoking cigarettes (\>1 in the past 30 days);
* English speaking;
* able to provide meaningful consent.

Exclusion Criteria:

* prior lung cancer,
* hearing impairment,
* cognitive impairment,
* household member already enrolled.

Where it's running

• Georgetown University Medical Center
  Washington D.C., District of Columbia, United States Recruiting

Study contacts

• Study coordinator: Kathryn L Taylor, PhD
• Email: taylorkl@georgetown.edu
• Phone: 2022159402

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Quitting Matters: a smoking quit program for people living with HIV

  This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.

  Recruiting Wake Forest University Health Sciences · Winston-Salem, North Carolina · NCT06883097

• Smoky Futures: Danish Adolescent Nicotine Use over Time

  This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.

  Recruiting University of Southern Denmark · Copenhagen · NCT07910331

• Nicotine Orodispersible Tablet to Relieve Cravings in Smokers

  A nicotine mint orodispersible tablet is tested vs placebo to see if it quickly eases the urge to smoke in adult cigarette smokers.

  Recruiting Phase 2 Kenvue Brands LLC · Mississauga, Ontario · NCT07893158

• Optimizing when weekly chatbot reminders go out to people using a chatbot for quitting smoking

  This study tests whether sending weekly reminders at different times helps people stay engaged with a chatbot smoking-cessation service.

  Recruiting The University of Hong Kong · Hong Kong · NCT07826884

• NMDA and Sigma-1 combination therapy for smoking cessation with AXS-05

  This phase 3 trial tests whether AXS-05 can help adults quit smoking better than placebo or bupropion.

  Recruiting at 28 sites Phase 3 Axsome Therapeutics, Inc. · Phoenix, Arizona and 27 other locations · NCT07766655

• AI-assisted interactive case-based training to improve smoking cessation counseling by medical interns

  This study tests whether AI-powered interactive case-based training helps medical interns provide better smoking cessation counseling.

  Recruiting Assiut University · Asyut, Assuit · NCT07650721

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.